Elevated free fatty acid levels inhibit glucose phosphorylation in slow-twitch rat skeletal muscle. 1994

L A Nolte, and D Galuska, and I K Martin, and J R Zierath, and H Wallberg-Henriksson
Department of Clinical Physiology, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden.

The effect of increased free fatty acid concentrations on glucose metabolism in rat skeletal muscle was investigated at several different steps in glucose metabolism including glucose transport, glucose phosphorylation, glucose oxidation and glycogen synthesis. In isolated soleus (slow-twitch) muscles, insulin-stimulated (100 microU ml-1) glucose phosphorylation, but not glucose transport, was inhibited by 26 and 22% in the presence of 1.0 and 2.0 mM oleate, respectively (P < 0.01). Regardless of oleate concentration (0.3 or 2.0 mM), insulin-stimulated glucose 6-phosphate levels were elevated to the same extent over the non-insulin-stimulated levels in soleus muscles (P < 0.01). Insulin-stimulated glucose oxidation was inhibited by 44% in soleus muscles exposed to 2.0 mM oleate (P < 0.05), whereas the rate of glucose incorporation into glycogen was not altered. In insulin-stimulated epitrochlearis (fast-twitch) muscles, elevated concentrations of oleate had no effect on the rates of glucose transport or glucose phosphorylation, or on the level of glucose 6-phosphate. These data suggest that increased free fatty acid availability decreases glucose utilization by selectively inhibiting glucose phosphorylation and oxidation in slow-twitch, but not fast-twitch skeletal muscle.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008757 Methylglucosides Methylglucopyranosides
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009829 Oleic Acids A group of fatty acids that contain 18 carbon atoms and a double bond at the omega 9 carbon. Octadecenoic Acids,Acids, Octadecenoic,Acids, Oleic
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010085 Oxidative Phosphorylation Electron transfer through the cytochrome system liberating free energy which is transformed into high-energy phosphate bonds. Phosphorylation, Oxidative,Oxidative Phosphorylations,Phosphorylations, Oxidative
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D003847 Deoxyglucose 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. 2-Deoxy-D-glucose,2-Deoxyglucose,2-Desoxy-D-glucose,2 Deoxy D glucose,2 Deoxyglucose,2 Desoxy D glucose
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids

Related Publications

L A Nolte, and D Galuska, and I K Martin, and J R Zierath, and H Wallberg-Henriksson
June 2004, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society,
L A Nolte, and D Galuska, and I K Martin, and J R Zierath, and H Wallberg-Henriksson
October 1984, General physiology and biophysics,
L A Nolte, and D Galuska, and I K Martin, and J R Zierath, and H Wallberg-Henriksson
October 1980, The Journal of physiology,
L A Nolte, and D Galuska, and I K Martin, and J R Zierath, and H Wallberg-Henriksson
January 1984, European journal of applied physiology and occupational physiology,
L A Nolte, and D Galuska, and I K Martin, and J R Zierath, and H Wallberg-Henriksson
October 1975, The Journal of physiology,
L A Nolte, and D Galuska, and I K Martin, and J R Zierath, and H Wallberg-Henriksson
September 2009, American journal of physiology. Regulatory, integrative and comparative physiology,
L A Nolte, and D Galuska, and I K Martin, and J R Zierath, and H Wallberg-Henriksson
January 2010, Journal of applied physiology (Bethesda, Md. : 1985),
L A Nolte, and D Galuska, and I K Martin, and J R Zierath, and H Wallberg-Henriksson
February 1999, Diabetes,
L A Nolte, and D Galuska, and I K Martin, and J R Zierath, and H Wallberg-Henriksson
March 1998, The American journal of physiology,
L A Nolte, and D Galuska, and I K Martin, and J R Zierath, and H Wallberg-Henriksson
December 2012, The journals of gerontology. Series A, Biological sciences and medical sciences,
Copied contents to your clipboard!